Clinical Trials Browser

Completed × Mesothelioma, Malignant × Everolimus × Clear all

NCT00770120 2020-03-06

S0722: Everolimus in Treating Patients With Pleural Malignant Mesothelioma That Cannot Be Removed By Surgery

Phase 2 Completed

61 enrolled 14 charts

Other solid neoplasmThoracic

Mesothelioma, Malignant

NCT01024946 2015-05-12

Everolimus (RAD001) for the Treatment of Malignant Pleural Mesothelioma With Merlin/NF2 Loss as a Biomarker to Predict Sensitivity

Phase 2 Completed

11 enrolled 6 charts

Other solid neoplasmThoracic

Mesothelioma, Malignant, Mesothelioma